OXOHEXESTROL DERIVATIVES LABELED WITH F-18 - SYNTHESIS, RECEPTOR-BINDING AND IN-VITRO DISTRIBUTION OF 2 NONSTEROIDAL ESTROGENS AS POTENTIALBREAST-TUMOR IMAGING AGENTS
Ke. Bergmann et al., OXOHEXESTROL DERIVATIVES LABELED WITH F-18 - SYNTHESIS, RECEPTOR-BINDING AND IN-VITRO DISTRIBUTION OF 2 NONSTEROIDAL ESTROGENS AS POTENTIALBREAST-TUMOR IMAGING AGENTS, Nuclear medicine and biology, 21(1), 1994, pp. 25-39
We have prepared two non-steroidal estrogens in the 2-oxohexestrol ser
ies labeled with the positron-emitting radionuclide fluorine-18, 1-flu
oro-5-oxohexestrol (4) and 1-fluoro-2-oxohexestrol (5). We anticipated
that the polar ketone function at the interior of these ligands would
reduce their level of non-specific binding, which might increase the
selectivity of their uptake in vivo. The two compounds were prepared b
y total synthesis: compound 4 was prepared in fluorine-lb labeled form
by [F-18]fluorine ion displacement on a suitably protected methanesul
fonate precursor followed by deprotection under acidic hydrogenolytic
conditions; the isomer 5 was prepared from a protected a-keto trifluor
omethanesulfonate precursor with deprotection under basic conditions a
s the final step. The binding affinity of these hexestrol derivatives
for the estrogen receptor was determined by competitive radiometric bi
nding assays at 0 and 25 degrees C, and their lipophilicity (as octano
l-water partition coefficients, log P values) and non-specific binding
were estimated. The log P values determined by a reversed phase HPLC
method were higher, relative to estradiol, than those calculated by th
e fragment method of Rekker. In tissue distribution studies in immatur
e (50 g) rats, both of these compounds showed selective uptake in estr
ogen target tissues. At 1 h, activity in the uterus reached the level
of 2.5-3.0% of the injected dose per gram tissue, with uterus-to-blood
and uterus-to-muscle ratios of 14-20 and 8-14, respectively. The upta
ke efficiency and selectivity of these fluoro-oxohexestrols in princip
al estrogen target tissues is less than that of fluorine-18 labeled st
eroidal estrogens we have prepared previously, but their receptor-medi
ated uptake in certain secondary target tissues is substantial. The sp
ecific and non-specific components of target tissue uptake of these tw
o compounds appear to be directly related to their non-specific bindin
g and their binding selectivity.